Efficacy and Safety of Concurrent Chemoradiotherapy With Oral Vinorelbine in Patients With Non-small Cell Lung Cancer
Clinical trial NCT06540950 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06540950
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-20
- Primary completion
- 2025-04-10
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.